Amphastar Pharmaceuticals, Inc. (AMPH) Net income 2016–2025
Amphastar Pharmaceuticals, Inc. (AMPH) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
$98.1MFY2025 · since FY2016: $9.8M → $98.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $98.1M | -38.5% |
| FY2024 | $159.5M | +16.0% |
| FY2023 | $137.5M | +50.5% |
| FY2022 | $91.4M | +47.1% |
| FY2021 | $62.1M | +4327.4% |
| FY2020 | $1.4M | -97.1% |
| FY2019 | $48.9M | +952.9% |
| FY2018 | -$5.7M | -257.3% |
| FY2017 | $3.6M | -62.9% |
| FY2016 | $9.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice